About Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, and endovascular specialty, as well as hospitalist and intensivist, and medical cost management services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers laboratory services that include general testing, clinical anatomic pathology, and molecular testing. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2016, it operated 3,624 dialysis clinics in approximately 45 countries worldwide. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany.
Industry, Sector and Symbol:
- 50 Day Moving Avg: €81.16
- 200 Day Moving Avg: €82.17
- Trailing P/E Ratio: 21.008
- P/E Growth: 0.000
- Net Margins: 7.56%
- Return on Equity: 10.85%
- Return on Assets: 5.37%
Frequently Asked Questions for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
What is Fresenius Medical Care AG & Co. (Pref)'s stock symbol?
Fresenius Medical Care AG & Co. (Pref) trades on the ETR under the ticker symbol "FME."
Where is Fresenius Medical Care AG & Co. (Pref)'s stock going? Where will Fresenius Medical Care AG & Co. (Pref)'s stock price be in 2017?
19 brokers have issued 12 month price targets for Fresenius Medical Care AG & Co. (Pref)'s shares. Their predictions range from €80.00 to €97.00. On average, they anticipate Fresenius Medical Care AG & Co. (Pref)'s share price to reach €89.46 in the next twelve months. View Analyst Ratings for Fresenius Medical Care AG & Co. (Pref).
Who are some of Fresenius Medical Care AG & Co. (Pref)'s key competitors?
Some companies that are related to Fresenius Medical Care AG & Co. (Pref) include Aareal Bank AG (ARL), Adler Real Estate AG (ADL), ADO Properties SA (ADJ), ADVA Optical Networking SE (ADV), Aixtron Se (AIXA), Aurubis AG (NDA), Basf Se (BAS), Bayerische Motoren Werke AG (BMW), BayWa AG (BYW6), Bechtle AG (BC8), Beiersdorf AG (BEI), Bertrandt AG (BDT), bet-at-home.com AG (ACX), Bilfinger SE (GBF), Biotest AG (BIO), Cancom SE (COK), Capital Stage AG (CAP) and Carl Zeiss Meditec AG (AFX).
Who are Fresenius Medical Care AG & Co. (Pref)'s key executives?
MarketBeat Community Rating for Fresenius Medical Care AG & Co. (Pref) (ETR FME)MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care AG & Co. (Pref) and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Fresenius Medical Care AG & Co. (Pref)'s management team includes the folowing people:
- Gerd Krick, Chairman of the Supervisory Board
- Rice Powell, Chairman of the Management Board, Chief Executive Officer
- Dieter Schenk, Vice Chairman of the Supervisory Board
- Michael Brosnan, Chief Financial Officer, Member of the Management Board
- Harry De Wit, Chief Executive Officer for Asia-Pacific, Member of the Management Board
- Olaf Schermeier, Chief Executive Officer for Global Research and Development, Member of the Management Board
- William Valle, Chief Executive Officer for North America, Member of the Management Board
- Kent Wanzek, Chief Executive Officer for Global Manufacturing & Quality, Member of the Management Board
- Dominik Wehner, Chief Executive Officer for Europe, Middle East and Africa (EMEA), Member of the Management Board
- Ben J. Lipps, Honorary Chairman
Consensus Ratings for Fresenius Medical Care AG & Co. (Pref) (ETR:FME) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||9 Hold Ratings, 10 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.53)|
|Consensus Price Target: ||€89.46|Consensus Price Target History for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
Analysts' Ratings History for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
(Data available from 10/18/2015 forward)
|10/11/2017||J P Morgan Chase & Co||Set Price Target||Buy||€95.10|
|9/29/2017||Goldman Sachs Group, Inc. (The)||Set Price Target||Buy||€97.00|
|9/19/2017||Berenberg Bank||Set Price Target||Buy||€95.60|
|9/15/2017||Morgan Stanley||Set Price Target||Buy||€90.00|
|8/8/2017||Citigroup Inc.||Set Price Target||Buy||€92.00|
|8/8/2017||Deutsche Bank AG||Set Price Target||Neutral||€84.00|
|8/8/2017||Independent Research GmbH||Set Price Target||Neutral||€88.00|
|8/7/2017||Commerzbank Ag||Set Price Target||Neutral||€88.00|
|8/3/2017||Nord/LB||Set Price Target||Buy||€93.00|
|8/2/2017||Kepler Capital Markets||Set Price Target||Buy||€95.00|
|8/2/2017||Jefferies Group LLC||Set Price Target||Neutral||€83.00|
|8/1/2017||S&P Global||Set Price Target||Buy||€95.00|
|7/20/2017||Oddo Securities||Set Price Target||Buy||€95.00|
|5/5/2017||Societe Generale||Set Price Target||Neutral||€90.00|
|4/26/2017||HSBC Holdings plc||Set Price Target||Neutral||€83.00|
|2/22/2017||Warburg Research||Set Price Target||Neutral||€85.00|
|10/27/2016||Bankhaus Lampe||Set Price Target||Neutral||€80.00|
|10/27/2016||S&P Global Inc.||Set Price Target||Neutral||€81.00|
|10/25/2016||Credit Suisse Group||Set Price Target||Buy||€90.00|
|8/9/2016||Barclays PLC||Set Price Target||Sell||€72.00|
|8/3/2016||BNP Paribas||Set Price Target||Neutral||€80.00|
|8/2/2016||Baader Bank||Set Price Target||Buy||€90.00|
|6/27/2016||Sanford C. Bernstein||Set Price Target||Buy||€92.00|
|5/24/2016||Bank of America Corporation||Set Price Target||Buy||€94.00|
|3/17/2016||Nomura||Set Price Target||Buy||€99.00|
|10/29/2015||S&P Equity Research||Set Price Target||Neutral||€79.00|
Earnings History for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
Latest Headlines for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)